Eisai

Rediff.com » News » Eisai

News for Eisai

Business

Eisai to invest $44 mn in India

Eisai Pharmaceuticals, the billion Japanese pharmaceuticals group, is planning to open a production and research unit in India next year.The group is expected to invest over yen 5 billion (close......

Medical devices industry eyes Rs 70,000 cr investment in 5 years

The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore,......

Japanese pharma firm sets up Indian subsidiary

Astellas Pharma, the second largest Japanese drug company, has set up a wholly-owned subsidiary in India, making it the third Japanese pharma major after Daiichi Sankyo and Eisai to tap the growing......

Lupin launches generic GERD drug in the US market

Drug major Lupin said on Monday it has launched a generic version of Japan-headquartered Eisai Inc's Aciphex delayed-release tablets, used to treat gastroesophageal reflux disease, in the US......

Ranbaxy gets US nod to sell Alzheimer's generic

India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US. The exclusivity......

Eisai

News for Eisai

Eisai to invest $44 mn in India

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Japanese pharma firm sets up Indian subsidiary

Lupin launches generic GERD drug in the US market

Ranbaxy gets US nod to sell Alzheimer's generic

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS